These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1175 related items for PubMed ID: 19696641

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: Maastricht experience.
    van den Berg-Loonen EM, Terasaki P, Kohanof S, Christiaans MH.
    Clin Transpl; 2006; ():305-22. PubMed ID: 18365386
    [Abstract] [Full Text] [Related]

  • 24. 14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis.
    Ozawa M, Terasaki PI, Castro R, Alberu J, Morales-Buenrostro L, Alvarez I, Toledo R, Alvez H, Monteiro M, Teixeira J, Campbell P, Ciszek M, Charron D, Gautreau C, Christiansen F, Langan L, Conca R, Grosse-Wilde H, Heinemann F, Kamoun M, Kobayashi T, Kupatawintu P, LeFor W, Mehra N, Panigrahi A, Norman D, Piazza A, Poli F, Roy R, Schonemann C, Lachmann N, Sireci G, Tanabe K, Ishida H, Van den Berg-Loonen E, Zeevi A.
    Clin Transpl; 2007; ():255-60. PubMed ID: 18642456
    [Abstract] [Full Text] [Related]

  • 25. Human leukocyte antigen antibodies and chronic rejection: from association to causation.
    Terasaki PI, Cai J.
    Transplantation; 2008 Aug 15; 86(3):377-83. PubMed ID: 18698239
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The clinical significance of human leukocyte antigen antibody development in kidney transplantation.
    Lee PC, Chen YL, Chou TC, Wang WM, Wang JD, Hung CJ, Chang SS, Lin YJ, Chan RH.
    Transplant Proc; 2012 Jan 15; 44(1):264-6. PubMed ID: 22310628
    [Abstract] [Full Text] [Related]

  • 28. Posttransplant major histocompatibility complex class I chain-related gene A antibodies and long-term graft outcomes in a multicenter cohort of 779 kidney transplant recipients.
    Lemy A, Andrien M, Lionet A, Labalette M, Noel C, Hiesse C, Delahousse M, Suberbielle-Boissel C, De Meyer M, Latinne D, Mourad M, Delsaut S, Racapé J, Wissing KM, Toungouz M, Abramowicz D.
    Transplantation; 2012 Jun 27; 93(12):1258-64. PubMed ID: 22466790
    [Abstract] [Full Text] [Related]

  • 29. Major histocompatibility complex class 1 chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes.
    Lemy A, Andrien M, Wissing KM, Ryhahi K, Vandersarren A, Racapé J, Heylen C, Ghisdal L, Broeders E, Vereerstraeten P, Toungouz M, Abramowicz D.
    Transplantation; 2010 Jul 27; 90(2):168-74. PubMed ID: 20463636
    [Abstract] [Full Text] [Related]

  • 30. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006 Jul 27; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation.
    Cox ST, Stephens HA, Fernando R, Karasu A, Harber M, Howie AJ, Powis S, Zou Y, Stastny P, Madrigal JA, Little AM.
    Hum Immunol; 2011 Oct 27; 72(10):827-34. PubMed ID: 21664940
    [Abstract] [Full Text] [Related]

  • 34. Effects of blood transfusions given after renal transplantation.
    Scornik JC, Schold JD, Bucci M, Meier-Kriesche HU.
    Transplantation; 2009 May 15; 87(9):1381-6. PubMed ID: 19424040
    [Abstract] [Full Text] [Related]

  • 35. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y, Ozdilli K, Oguz F, Karahan G, Onal E, Turkmen A, Eldegez U, Nane I, Çalişkan Y, Bakkaloglu H, Carin M.
    Transplant Proc; 2012 May 15; 44(6):1660-6. PubMed ID: 22841239
    [Abstract] [Full Text] [Related]

  • 36. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E, Castro-Panete MJ, Castillo-Rama M, Morales P, Lora-Pablos D, Valero-Hervás D, Ruiz-García R, Apaza J, Talayero P, Andrés A, Morales JM, Paz-Artal E.
    Transplantation; 2013 Jul 15; 96(1):70-8. PubMed ID: 23624543
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.
    Transplantation; 2009 Jan 15; 87(1):94-9. PubMed ID: 19136897
    [Abstract] [Full Text] [Related]

  • 40. HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report.
    Süsal C, Döhler B, Sadeghi M, Ovens J, Opelz G.
    Transplantation; 2009 May 15; 87(9):1367-71. PubMed ID: 19424037
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 59.